PMV Pharmaceuticals to Participate at Upcoming Investor Conferences in March

Rhea-AI Summary

PMV Pharmaceuticals (Nasdaq: PMVP) is set to participate in two key investor conferences in March 2023. CEO David H. Mack will represent the company at Cowen’s 43rd Annual Health Care Conference on March 8, where he'll join a panel discussing tumor diagnostic development at 9:10 AM ET. Following this, he will take part in Oppenheimer’s 33rd Annual Healthcare Conference on March 13, featuring a fireside chat at 8 AM ET. PMV Pharma specializes in developing small molecule, tumor-agnostic therapies targeting p53, a protein associated with nearly half of all cancers. For more information, visit www.pmvpharma.com.

PRINCETON, N.J., Feb. 28, 2023 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP; “PMV Pharma”), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today announced that David H. Mack, Ph.D., President and Chief Executive Officer, will participate at the following investor conferences in March.

Cowen’s 43rd Annual Health Care Conference (March 6-8, 2023)
Format:	Tumor Diagnostic Development Corporate Panel
Date:	Wednesday, March 8, 2023
Time:	9:10 – 10:20 AM ET
Oppenheimer’s 33rd Annual Healthcare Conference (March 13-15, 2023)
Format:	Fireside Chat
Date:	Monday, March 13, 2023
Time:	8 AM ET

About PMV Pharma

PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53. p53 mutations are found in approximately half of all cancers. The field of p53 biology was established by our co-founder Dr. Arnold Levine when he discovered the p53 protein in 1979. Bringing together leaders in the field to utilize over four decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus. PMV Pharma is headquartered in Princeton, New Jersey. For more information, please visit www.pmvpharma.com.

Contacts

Investor Contact:
Winston Kung
PMV Pharmaceuticals, Inc.
investors@pmvpharma.com

Media Contact:
Kathy Vincent
Greig Communications
kathy@greigcommunications.com

FAQ

What events will PMV Pharmaceuticals participate in March 2023?

PMV Pharmaceuticals will participate in Cowen’s 43rd Annual Health Care Conference on March 8 and Oppenheimer’s 33rd Annual Healthcare Conference on March 13, 2023.

Who is representing PMV Pharmaceuticals at the March 2023 conferences?

David H. Mack, the President and CEO of PMV Pharmaceuticals, will represent the company at the investor conferences in March 2023.

What is the focus of PMV Pharmaceuticals?

PMV Pharmaceuticals focuses on precision oncology, specifically developing small molecule, tumor-agnostic therapies targeting the p53 protein, which is mutated in about half of all cancers.

When will PMV Pharmaceuticals speak at Cowen’s Health Care Conference?

PMV Pharmaceuticals will participate in a corporate panel at Cowen’s Health Care Conference on March 8, 2023, from 9:10 AM to 10:20 AM ET.

What time will PMV Pharmaceuticals' fireside chat at Oppenheimer’s Conference take place?

The fireside chat featuring PMV Pharmaceuticals at Oppenheimer’s Conference is scheduled for March 13, 2023, at 8 AM ET.